Helen Kuhlman

Helen is Chief Business Officer at Evgen Pharma plc. She has over 20 years’ experience in scientific and business roles for both public and private R&D-based biotechnology companies as well as in government funding and equity investment. She was previously Vice-President of Corporate Development at Chronos Therapeutics Ltd and while at Innovate UK, she created and delivered the £180m Biomedical Catalyst competitive grant scheme funded by the UK government. Helen holds a PhD in physiology and pharmacology from the University of Leicester, UK.